Skip to content

Resistance to extinction in appetitive and aversive conditioning of the sexual response

Resistance to extinction in appetitive and aversive conditioning of the sexual response - Extinction in appetitive and aversive sexual conditioning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35474
Enrollment
60
Registered
2011-12-22
Start date
2011-12-23
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seksuele aandoeningen hypersexuality hyposexuality sexual motivation disorders

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 45 years - Body Mass Index (BMI) > 19 - Heterosexual orientation

Exclusion criteria

Exclusion criteria: - Pregnancy or lactation - A diagnosis of affective, psychotic or substance related disorder according to DSM-IV-TR - Having undergone a hysterectomy or prolapse surgery - Current or recurrent use (less than 4 weeks before participation) of medication that may affect sexual response. To determine possible sexual side-effects the *Farmacotherapeutisch kompas* 2011 will be used. - Current or previous disorders of the genitals that may influence the sexual response or the measurement of the response - Other medical disorders that may influence the sexual response or the measurement of the response.

Design outcomes

Primary

MeasureTime frame
Results from the fysiological measurement of sexual arousal (vaginal pulse amplitude (VPA) is assessed by a vaginal photoplethysmograph; and penile circumference changes ), subjective ratings of valence and sexual arousal (results from questionnaires), automatic approach tendencies (results from an implicit approach/avoidance computertask).

Secondary

MeasureTime frame
n.v.t.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)